Obligacje AZN
Poniżej znajduje się lista obligacji korporacyjnych ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|
 US46353AM0ASTRAZENECA PLC 15/45 | 4,83% | 4,38% | 2045-11-16 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| US46353AU2ASTRAZENECA 18/48 | 4,79% | 4,38% | 2048-08-17 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| ZEGBASTRAZENECA PLC 12/42 | 4,72% | 4,00% | 2042-09-18 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| AZN.GEAstraZeneca 6.45% 15-SEP-2037 | 4,63% | 6,45% | 2037-09-15 | 2,75 B USD | 1 000,00 USD | 1 000,00 USD | AstraZeneca PLC |
| US46353AZ1ASTRAZENECA 21/51 | 4,60% | 3,00% | 2051-05-28 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| US46353AX6ASTRAZENECA 20/50 | 4,49% | 2,13% | 2050-08-06 | 500 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| UUS4636NAN3ASTRAZEN.FI. 24/34 | 4,38% | 5,00% | 2034-02-26 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| US46353AL2ASTRAZENECA PLC 15/25 | 4,25% | 3,38% | 2025-11-16 | 2 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| AAZN5549116AstraZeneca Finance LLC 4.875% 03-MAR-2033 | 4,24% | 4,88% | 2033-03-03 | 500 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| 50UCASTRAZENECA PLC 5.75% SNR EMTN 13/11/2031 | 4,15% | 5,75% | 2031-11-13 | 350 M GBP | 1 000,00 GBP | 50 000,00 GBP | AstraZeneca PLC |
| UUS4636NAM5ASTRAZEN.FI. 24/31 | 4,12% | 4,90% | 2031-02-26 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| AAZN5193314AstraZeneca Finance LLC 2.25% 28-MAY-2031 | 4,09% | 2,25% | 2031-05-28 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| UUS4636NAL7ASTRAZEN.FI. 24/29 | 4,08% | 4,85% | 2029-02-26 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| UUS4636NAK9ASTRAZEN.FI. 24/27 | 4,03% | 4,80% | 2027-02-26 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| AAZN5549115AstraZeneca Finance LLC 4.9% 03-MAR-2030 | 4,03% | 4,90% | 2030-03-03 | 650 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| US46353AV0ASTRAZENECA 20/26 | 4,00% | 0,70% | 2026-04-08 | 1,2 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| US46353AW8ASTRAZENECA 20/30 | 3,99% | 1,38% | 2030-08-06 | 1,3 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| US46353AT5ASTRAZENECA 18/29 | 3,96% | 4,00% | 2029-01-17 | 1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| UUS4636NAA1ASTRAZEN.FI. 21/26 | 3,95% | 1,20% | 2026-05-28 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| US46353AN8ASTRAZENECA PLC 17/27 | 3,93% | 3,13% | 2027-06-12 | 750 M USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca PLC |
| AAZN5193317AstraZeneca Finance LLC 1.75% 28-MAY-2028 | 3,92% | 1,75% | 2028-05-28 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| AAZN5549114AstraZeneca Finance LLC 4.875% 03-MAR-2028 | 3,92% | 4,88% | 2028-03-03 | 1,1 B USD | 1 000,00 USD | 2 000,00 USD | AstraZeneca Finance LLC |
| XXS287290977ASTRAZEN.FI. 24/33 MTN | 3,18% | 3,28% | 2033-08-05 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca Finance LLC |
| XS259310547ASTRAZENECA 23/32 MTN | 3,10% | 3,75% | 2032-03-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC |
| XXS287290969ASTRAZEN.FI. 24/30 MTN | 2,97% | 3,12% | 2030-08-05 | 650 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca Finance LLC |
| XS259310539ASTRAZENECA 23/27 MTN | 2,87% | 3,63% | 2027-03-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC |
| XS234766350ASTRAZENECA 21/29 MTN | 2,77% | 0,38% | 2029-06-03 | 800 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC |
| XS141140442ASTRAZENECA 16/28 MTN | 2,56% | 1,25% | 2028-05-12 | 800 M EUR | 1 000,00 EUR | 100 000,00 EUR | AstraZeneca PLC |